VBI VACCINES INC.

(VBIV)
  Report
Delayed Nasdaq  -  04:00 2022-08-12 pm EDT
1.220 USD   +10.91%
08/08VBI VACCINES : Reports Second Quarter 2022 Financial Results and Provides Corporate Update - Form 8-K
PU
08/08VBI VACCINES INC/BC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
08/08Earnings Flash (VBIV) VBI VACCINES Posts Q2 Revenue $346,000
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Earnings Per Share (EPS): Change in analysts' estimates
Turnover: Change in analysts' estimates
EPS consensus revisions
Next year EPS consensus revisions
Revenue consensus revisions
Next year Revenue consensus revisions